Suppr超能文献

脑转移瘤切除腔立体定向放射外科治疗后局部肿瘤控制概率的剂量反应模型。

A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.

作者信息

Gui Chengcheng, Grimm Jimm, Kleinberg Lawrence Richard, Zaki Peter, Spoleti Nicholas, Mukherjee Debraj, Bettegowda Chetan, Lim Michael, Redmond Kristin Janson

机构信息

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.

Department of Radiation Oncology, University of Washington, Seattle, Washington.

出版信息

Adv Radiat Oncol. 2020 Jun 24;5(5):840-849. doi: 10.1016/j.adro.2020.06.007. eCollection 2020 Sep-Oct.

Abstract

PURPOSE

Recent randomized controlled trials evaluating stereotactic surgery (SRS) for resected brain metastases question the high rates of local control previously reported in retrospective studies. Tumor control probability (TCP) models were developed to quantify the relationship between radiation dose and local control after SRS for resected brain metastases.

METHODS AND MATERIALS

Patients with resected brain metastases treated with SRS were evaluated retrospectively. Melanoma, sarcoma, and renal cell carcinoma were considered radio-resistant histologies. The planning target volume (PTV) was the region of enhancement on T1 post-gadolinium magnetic resonance imaging plus a 2-mm uniform margin. The primary outcome was local recurrence, defined as tumor progression within the resection cavity. Cox regression evaluated predictors of local recurrence. Dose-volume histograms for the PTV were obtained from treatment plans and converted to 3-fraction equivalent doses (α/β = 12 Gy). TCP models evaluated local control at 1-year follow-up as a logistic function of dose-volume histogram data.

RESULTS

Among 150 cavities, 41 (27.3%) were radio-resistant. The median PTV volume was 14.6 mL (range, 1.3-65.3). The median prescription was 21 Gy (range, 15-25) in 3 fractions (range, 1-5). Local control rates at 12 and 24 months were 86% and 82%. On Cox regression, larger cavities (PTV > 12 cm) predicted increased risk of local recurrence ( = .03). TCP modeling demonstrated relationships between improved 1-year local control and higher radiation doses delivered to radio-resistant cavities. Maximum PTV doses of 30, 35, and 40 Gy predicted 78%, 89%, and 94% local control among all radio-resistant cavities, versus 69%, 79%, and 86% among larger radio-resistant cavities.

CONCLUSIONS

After SRS for resected brain metastases, larger cavities are at greater risk of local recurrence. TCP models suggests that higher radiation doses may improve local control among cavities of radio-resistant histology. Given maximum tolerated doses established for single-fraction SRS, fractionated regimens may be required to optimize local control in large radio-resistant cavities.

摘要

目的

近期评估立体定向放射手术(SRS)治疗脑转移瘤切除术后局部控制率的随机对照试验,对既往回顾性研究中报道的高局部控制率提出了质疑。本研究开发了肿瘤控制概率(TCP)模型,以量化SRS治疗脑转移瘤切除术后放射剂量与局部控制之间的关系。

方法与材料

对接受SRS治疗的脑转移瘤切除术后患者进行回顾性评估。黑色素瘤、肉瘤和肾细胞癌被视为放射抗拒性组织学类型。计划靶体积(PTV)为钆增强T1加权磁共振成像上的强化区域加上2mm的均匀边界。主要结局为局部复发,定义为切除腔内肿瘤进展。Cox回归分析评估局部复发的预测因素。从治疗计划中获取PTV的剂量体积直方图,并转换为3分次等效剂量(α/β = 12 Gy)。TCP模型将1年随访时的局部控制评估为剂量体积直方图数据的逻辑函数。

结果

在150个切除腔中,41个(27.3%)为放射抗拒性。PTV体积中位数为14.6 mL(范围1.3 - 65.3)。中位处方剂量为21 Gy(范围15 - 25),分3次给予(范围1 - 5)。12个月和24个月时的局部控制率分别为86%和82%。Cox回归分析显示,较大的切除腔(PTV > 12 cm)预测局部复发风险增加(P = 0.03)。TCP模型显示,提高1年局部控制率与向放射抗拒性切除腔给予更高放射剂量之间存在相关性。PTV最大剂量为30、35和40 Gy时,预测所有放射抗拒性切除腔的局部控制率分别为78%、89%和94%,而较大放射抗拒性切除腔的局部控制率分别为69%、79%和86%。

结论

SRS治疗脑转移瘤切除术后,较大的切除腔局部复发风险更高。TCP模型表明,更高的放射剂量可能改善放射抗拒性组织学类型切除腔的局部控制。鉴于单次分割SRS已确定的最大耐受剂量,可能需要采用分次照射方案来优化大的放射抗拒性切除腔的局部控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3473/7557194/88e5dd5b0589/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验